Has Scott Gold, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,908 in general payments to Scott Gold, MD across 8 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Scott Gold, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Scott Gold, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Scott Gold, MD

Otolaryngology · New York, NYNPI 1669585394

Payments from drug & device makers

$2,908in general payments, 2019–2025

Across 8 payments — averaging $363.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$3K
Acclarent, Inc$180
Smith+Nephew$107
Aerin Medical Inc.$81

What the payments were for

Food & beverage$42915%
Other$2,47985%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	3	$2,540
Acclarent, Inc	2	$180
Smith+Nephew	1	$107
Aerin Medical Inc.	2	$81

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,908 in reported general payments places this provider in the 65th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York →

Medicare billing

Part B allowed, 2024

$345,839

Medicare patients

953

Services billed

3,088

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Famotidine	906	$8,410
OmnarisCiclesonide	17	$4,721
Ipratropium Bromide	172	$3,780
Fluocinolone Acetonide Oil	89	$3,672
Azelastine-FluticasoneAzelastine/Fluticasone	30	$3,309
DymistaAzelastine/Fluticasone	11	$2,326
Mometasone Furoate	27	$1,727
Azelastine Hcl	82	$1,719
Pantoprazole Sodium	90	$777
Fluticasone Propionate	75	$743
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	84	$713
Lansoprazole	15	$551
Ofloxacin	22	$313
Omeprazole	38	$301
Doxycycline Hyclate	23	$248

Paid to pharmacies, not to this prescriber.

Other otolaryngology in New York

Anthony DelsignoreNew York$966K
Roheen RaithathaNew York$882K
Dennis KrausNew York$524K
Ashutosh KackerNew York$387K
Lawrence LustigNew York$383K
Brett MilesNew York$368K
Alfred Marc IloretaNew York$342K
Hae-Ok KimNew York$104K
Gregory LevitinNew York$48K
David KaufmanNew York$42K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →